Immunization and Host Responses to MB-1, a Live Hatchery Vaccine against Infectious Bursal Disease

MB-1 is an attenuated infectious bursal disease virus vaccine. Previously, we observed a temporal delay of vaccine virus replication in the bursae of chicks due to maternally derived antibodies (MDAs). The mechanism that allowed its survival despite MDA neutralization remained unclear. We hypothesized that after vaccination at 1 day of age (DOA), the MB-1 virus penetrates and resides in local macrophages that are then distributed to lymphoid organs. Furthermore, MB-1's ability to survive within macrophages ensures its survival during effective MDA protection. PCR analysis of lymphoid organs from chicks with MDA, vaccinated on 1 DOA, demonstrated that the MB-1 virus was identified at low levels solely in the spleen pre-14 days of age. Fourteen days after vaccination, the virus was identified using PCR in the bursa, with viral levels increasing with time. The possible delay in viral colonization of the bursa was attributed to the presence of anti-IBDV capsid VP2 maternal IgA and IgY in the bursa interstitium. These indicate that during the period of high MDA levels, a small but viable MB-1 viral reservoir was maintained in the spleen, which might have served to colonize the bursa after MDA levels declined. Thereafter, individual immunization of chicks against Gumboro disease was achieved.

Automated summary

MB-1 is a attenuated infectious bursal disease virus vaccine. It was observed that the vaccine virus replicated with a temporal delay due to maternally derived antibodies (MDAs). The mechanism of its survival despite MDA neutralization remained unclear. After vaccination at 1 day of age, MB-1 virus penetrates and resides in local macrophages, which are then distributed to lymphoid organs. The ability of MB-1 to survive within macrophages ensures its survival during effective MDA protection.